ÂÜÀòÂÒÂ×

Julia Pronina has extensive work experience in financial planning and analysis, with a focus on pharmaceutical and tax service industries. Julia is currently the Director of Financial Planning & Analysis at Intercept Pharmaceuticals since August 2022. Prior to this, they held the position of Associate Director of Financial Planning & Analysis at the same company from February 2021 to August 2022.

Before joining Intercept Pharmaceuticals, Julia worked as a Senior Manager of Financial Planning & Analysis at Jackson Hewitt Tax Service Inc. from May 2018 to February 2021. Julia also held various roles at Bristol Myers Squibb, including Finance Manager of Pharma Operations from March 2015 to March 2018, Manager of International Treasury from September 2012 to February 2015, and Finance Associate from September 2010 to August 2012.

Earlier in their career, Julia worked as a Senior Manager of Transfer Pricing at Thomson Reuters from August 2002 to May 2008. Julia started their career as a Transfer Pricing Analyst at Arthur Andersen LLP in 2000.

Overall, Julia Pronina has demonstrated expertise in financial planning and analysis, with a strong background in the pharmaceutical and tax service sectors.

Julia Pronina pursued their education at New York University from 1997 to 1999, where they obtained a Bachelor's degree in Economics. Julia furthered their educational journey at Columbia Business School from 2008 to 2010, acquiring a Master's degree in Business Administration with a specialization in Finance.